515亿温州富豪,28亿吞并苏州药企

21世纪经济报道
Jan 16

温州医药首富李革,拿下一家同行。  1月14日晚,他实控的药明合联,宣布将以现金要约方式,以31亿港元的估值,约合28亿人民币,控股东曜药业。  李革的药明系较为慷慨,出价4港元/股,相较12月下旬2港元左右的股价,刚好溢价一倍,考虑部分购股权注销价为1.7665港元,其要约最高代价约27.9亿港元。  东曜药业是行业新兵,2020年才转型从事合同外包服务(CDMO),其有李氏所看重的ADC(抗体...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10